OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 08, 2021
Moderna’s new facility is expected to produce 500 million vaccine doses per year.
October 07, 2021
The agency’s human medicines committee approved an additional site in West Point, Pa. in the United States for the manufacture of Janssen’s COVID-19 vaccine.
September 24, 2021
Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.
September 23, 2021
In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.
New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19.
September 09, 2021
Moderna’s new single-dose vaccine will be a booster for both COVID-19 and the flu.
September 03, 2021
Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.
August 17, 2021
Primates inoculated with CV2CoV show improved immune response and protection from various COVID variants.
August 13, 2021
PNI expands global headquarters with a new 75,000-square-foot facility, which will include multiple GMP suites for manufacturing RNA therapeutics and vaccines.
August 12, 2021
A research team at the Keck Graduate Institute will work to adapt its decade-long low-cost vaccine R&D for developing countries into a COVID-19 vaccine.